Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$3.65 - $4.82 $868,156 - $1.15 Million
237,851 Added 87.62%
509,321 $2.28 Million
Q3 2022

Nov 14, 2022

BUY
$2.66 - $3.97 $211,371 - $315,468
79,463 Added 41.39%
271,470 $988,000
Q2 2022

Aug 12, 2022

BUY
$2.42 - $4.05 $464,656 - $777,628
192,007 New
192,007 $508,000
Q1 2022

May 16, 2022

SELL
$3.45 - $5.83 $242,452 - $409,709
-70,276 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $343,649 - $533,394
70,276 New
70,276 $387,000
Q4 2020

Feb 16, 2021

SELL
$2.78 - $4.5 $127,607 - $206,559
-45,902 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$2.12 - $3.53 $97,312 - $162,034
45,902 New
45,902 $160,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $81,369 - $162,738
-35,378 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$2.9 - $9.56 $102,596 - $338,213
35,378 New
35,378 $102,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.